INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 41 filers reported holding INMUNE BIO INC in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $283,325 | -40.3% | 41,850 | -19.9% | 0.00% | – |
Q2 2023 | $474,430 | +36.9% | 52,250 | -2.6% | 0.00% | – |
Q1 2023 | $346,540 | +21.4% | 53,644 | +19.1% | 0.00% | – |
Q4 2022 | $285,490 | +15.1% | 45,030 | +12.7% | 0.00% | – |
Q3 2022 | $248,000 | -27.9% | 39,950 | +2.6% | 0.00% | – |
Q2 2022 | $344,000 | +13.5% | 38,950 | +8.3% | 0.00% | – |
Q1 2022 | $303,000 | -17.4% | 35,950 | 0.0% | 0.00% | – |
Q4 2021 | $367,000 | -37.3% | 35,950 | +19.3% | 0.00% | – |
Q3 2021 | $585,000 | +346.6% | 30,126 | +304.6% | 0.00% | – |
Q2 2021 | $131,000 | +235.9% | 7,446 | +125.0% | 0.00% | – |
Q1 2021 | $39,000 | +875.0% | 3,309 | +1223.6% | 0.00% | – |
Q4 2020 | $4,000 | 0.0% | 250 | -69.5% | 0.00% | – |
Q2 2020 | $4,000 | 0.0% | 820 | -27.4% | 0.00% | – |
Q1 2020 | $4,000 | – | 1,129 | +2158.0% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 50 | -92.7% | 0.00% | – |
Q3 2019 | $4,000 | +100.0% | 686 | +139.0% | 0.00% | – |
Q2 2019 | $2,000 | -77.8% | 287 | -76.3% | 0.00% | – |
Q1 2019 | $9,000 | – | 1,209 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 230,500 | $2,351,000 | 1.70% |
Fermata Advisors, LLC | 17,955 | $183,000 | 0.07% |
Virtu Financial LLC | 24,364 | $249,000 | 0.02% |
YorkBridge Wealth Partners, LLC | 10,369 | $106,000 | 0.02% |
Jump Financial, LLC | 21,100 | $215,000 | 0.01% |
Financial Advocates Investment Management | 15,167 | $155,000 | 0.01% |
FNY Investment Advisers, LLC | 1,100 | $11,000 | 0.01% |
Janney Montgomery Scott LLC | 113,914 | $1,162,000 | 0.01% |
Walleye Capital LLC | 17,127 | $175,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 12,473 | $127,000 | 0.00% |